![Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/ee95e9a306b2de272195198c15a150ca4e0abb19-758x424.png/1712theo-table1.png?fit=crop&auto=format)
Clinical Decision Making in Surveillance of Non–Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers
![COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 * TO DETECT BLADDER CANCER | Journal of Urology COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 * TO DETECT BLADDER CANCER | Journal of Urology](https://www.auajournals.org/cms/asset/8ec79c1f-8ffe-4171-98d7-55db34afd276/si2.gif)
COMPARATIVE SENSITIVITY OF URINARY CYFRA 21-1, URINARY BLADDER CANCER ANTIGEN, TISSUE POLYPEPTIDE ANTIGEN AND NMP22 * TO DETECT BLADDER CANCER | Journal of Urology
![Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use - eBioMedicine Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use - eBioMedicine](https://www.thelancet.com/cms/attachment/67dd703f-1909-4478-b62d-b081f934c7fa/gr1.jpg)
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use - eBioMedicine
![Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles](https://www.mdpi.com/cancers/cancers-12-01400/article_deploy/html/images/cancers-12-01400-g001.png)
Cancers | Free Full-Text | Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles
Why do we need Urine Markers? - Activity Two:<br>Understanding Biomarker Performance for Bladder Cancer Surveillance - Educational Centre:<br>Current Clinical Problems in Bladder Cancer
Urinary Tumor Markers For Bladder Cancer I. Policy Description II. Related Policies III. Indications and/or Limitations of Cover
Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes | PLOS ONE
Cell-Free Urinary MicroRNA-99a and MicroRNA-125b Are Diagnostic Markers for the Non-Invasive Screening of Bladder Cancer | PLOS ONE
![Urinary biomarkers in bladder cancer: A review of the current landscape and future directions - ScienceDirect Urinary biomarkers in bladder cancer: A review of the current landscape and future directions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143920303689-gr1.jpg)
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions - ScienceDirect
![Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers - European Urology Oncology Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers - European Urology Oncology](https://euoncology.europeanurology.com/cms/asset/5d246279-32ad-4a4d-bf2d-a163212a376d/gr1.jpg)